As director Centre for Sustainable Health Innovations, Singapore she leads the tripartite InnovationS for UHC Collaborative to catalyze south-south dialogues around leveraging low-cost technological innovations and new models of healthcare in Asia and Africa. She is also co-founder of the Mutual Learning Platform for Mixed Health Systems launched in 2020 in response to the COVID 19 pandemic that convenes the private sector and public health stakeholders for evidence sharing and building interventional capacity for stronger health systems. Her projects on health technology includes a partnership with the Consortia of Affordable Technologies (CamTech) which mentors and seed-funds early stage social impact health innovations in Asia and Africa and the Grand Challenges Grant winner, the Biodiaspora Partnership that tracks and models infectious and vector borne disease through human movement patterns.

As senior public health scientist at the Public Health Foundation of India, she directs the Universal Health Coverage Initiative part of one of India’s seminal health policy exercises on health system reform. She was secretariat director for the government of India’s High Level Expert Group recommendations on universal health coverage, part of the country’s 12th Five Year Plan.

Dr. Balasubramaniam has authored several reports, policy briefs as well as peer-reviewed publications over her career as both a clinician and researcher. She works closely with municipal and state governments regionally and served on a taskforce on primary healthcare constituted Ministry of Health and Family Welfare, government of India and was a member of the technical review group on urban health constituted by the Ministry of Urban Development. She serves on the editorial board of the International Journal of Health Governance, was recently appointed to the editorial board of the newly launched Oxford Open Journal of Infrastructure and Health, and is regional editorial advisor to Oxford University Press’s Healthy Cities and Communities Encyclopaedia. Dr. Balasubramaniam holds visiting faculty positions at the National University of Singapore and the Keenan Research Centre, Toronto, Canada. She is a frequent advisor on health systems and policy to numerous multi-bi lateral organizations including WHO, IDRC Canada, the European Commission, the World Bank, the Wellcome Trust, USAID, DfID, and the Bill & Melinda Gates Foundation.

The post Priya Balasubramaniam appeared first on Results for Development.

1. Engaging Stakeholders to Turn Research into Policy Amid Political Change
October 18, 11 am (GMT -5)
Virtual
Featuring:
– Ama Pokuaa Fenny, Senior Fellow
– Alexandre Delamou, Senior Consultant

2. Advancing Equity in Health Systems Strengthening: Four Key Approaches to Enhance Equity in Implementation and outcomes
October 20, 12 pm (GMT -5)
Virtual
Featuring:
– Linda Vanotoo, Ghana Country Director
– Leah Ewald, Senior Program Officer

3.  What keeps us from separating ends and means in health reform?
October 31, 8 am – 4 pm (GMT -5)
Level 3, Room LM
Featuring:
– Agnes Gatome-Munyua, Associate Director
– Cheryl Cashin, Managing Director
– Nathaniel Otoo, Senior Fellow

4. PHCPI PCN Community of Practice Showcase
November 1, 8 – 10 am (GMT -5)
Hilton Bogota Conferias and virtual (link to come)
Featuring:
– Laurel Hatt, Senior Program Director and Practice Lead, Sustainable and Equitable Health Financing
– Amanda Folsom, Senior Program Director and Practice Lead, Collaborative Learning
– Linda Babalola, Senior Program Officer
– Emma Satzger, Senior Operations Associate

5. Contribution of the Private Sector in Health Systems Resilience and Reform (Hybrid private sector satellite session)
November 1, 8:30 am – 4 pm (GMT -5)
Level 2, Room BC
Featuring:
– Sarbani Chakraborty, Senior Program Director and Practice Lead, Mixed Health Systems
– Amit Bhanot, Technical Director of the Frontier Health Markets program
– Farhan Yusuf, Chief of Party of the Frontier Health Markets program

6. Promoting intersectoral collaboration through knowledge translation: lessons from the Partnership for Evidence and Equity in Responsive Social Systems (PEERSS)
November 1, 12:30 – 4 pm (GMT -5)
Level 3, Room K
Featuring:
– Abeba Taddese, Senior Program Director and Practice Lead, Evidence to Policy

7. Rehabilitation in health systems: Responding to changing population needs
November 2, 6:30 – 8:30 AM (GMT -5)
Featuring:
– Tamara Chikhradze, Associate Director
– Adeel Ishtiaq, Associate Director

In addition, R4D is involved in the following oral and poster presentations:

• “Evidence that a global peer-to-peer learning platform was effective in supporting immunization programs’ successful and sustainable transition from Gavi assistance” (poster)
• “Co-creation: an innovative approach for improving multi-sectoral collaboration and coordination for accelerating progress toward Universal Health Coverage (UHC) in Togo” (poster)
• “Reimagining Health Care Delivery Models for Equity in Ghana: Implementation Research on Primary Care Provider Networks” (poster)
• “Raising the visibility of NTDs in the discussion of domestic health resource allocation: Lessons from Colombia, Guatemala, and the Philippines” (poster)
• “An approach to integrating and scaling up mental health services as part of comprehensive primary health care in Liberia: Lessons and challenges in pandemic times” (oral); November 2, 2022, 11:00-12:30, Room N

Posters will be available for viewing from November 2-4 on the 3^rd level of the Agora Convention Centre.

Finally, come find us at the Health Systems Strengthening Accelerator booth, located at E7 on the 4th floor of the main conference center.

The post R4D at the 2022 Health Systems Research Symposium in Colombia appeared first on Results for Development.

Ensuring children have the treatment they need to fight pneumonia

Learn how R4D's market shaping approach helps pneumonia treatment reach children in need.

Read more

Since 2015, Results for Development has been supporting the government of Tanzania in implementing a holistic market shaping program focused on increasing access to Amox DT in the public and private sectors, by utilizing holistic market shaping approaches as well as evaluation and adaptive learning modalities to address the identified barriers to access to Amox DT.

These briefs summarize key findings from analysis and interventions undertaken in the program so far as well as recommended further action.

Key actions on the public sector to date include: (i) Establishing an aligned policy environment to ensure Amox DT is included on national medicine lists and all relevant treatment guidelines; (ii) Strengthening ownership and sustainability of procurement processes by supporting the transition from an external procurement agency to the country’s national procurement agency; (iii) Sourcing and administration of catalytic financing complemented by government-led resource mobilization through the implementation of co-financing agreements and (iv) Strengthening quantification and supply planning methods to accurately account for Amox DT needs in the country. These activities have contributed to a marked increase in availability of Amox DT across public health facilities from 25% in 2016 to 90% in 2022 as well as a corresponding decrease in Amox DT stockouts, from 59% in 2017 to 14% in 2022.

On the private sector key actions to date include ensuring a well-enabled policy environment; developing a holistic Pediatric amoxicillin market view which has been shared broadly with partners to increase transparency across the supply chain; and piloting the impact of ADDO (Accredited Drug Dispensing Outlet) sensitization efforts on improving knowledge, stocking, and dispensing behaviors. These activities have resulted in an increase in the number of registered Amox DT suppliers from one to eight since 2014, and a 6-fold increase in import volumes of Amox DT from 2016-2020 in the private sector.

R4D Staff who contributed to the briefs

Private Sector Policy Brief: Cammie Lee, Nelsha Haji, Yangzom Tshewang, Sarah Wangilisasi, Kimberly Churchwell, Pili Mmbaga

Public Sector Policy Brief: Cammie Lee, Aalia Chatur, Yangzom Tshewang, Taylor Salisbury, Sarah Wangilisasi, Kimberly Churchwell

Downloads

The post Reducing Child Mortality in Tanzania by Increasing Access to Pediatric Pneumonia Treatment appeared first on Results for Development.

As an associate director at Result for Development’s (R4D) evaluation and adaptive learning (EAL) practice, Ms. Rosapep provides technical and strategic leadership to EAL’s flagship initiatives. She also leads processes to review and analyze evidence to inform priorities for action and facilitates collaboration with consortium partners, USAID representatives, government stakeholders, and local implementing partners. In addition, she supports the growth and strategy development for the practice.

In her career, Ms. Rosapep has helped government and non-government stakeholders identify ways to improve in-service training for health care workers, expand service availability and accessibility to people living with HIV, pinpoint weaknesses in TB treatment initiation protocols, help community-level drug shops relay health messaging more effectively to their customers. By using iterative and participatory evaluation approaches she helped to adapt a peer sexual-health education program and explore the implications of modifying staffing configurations for early education interventions.

Before joining R4D, Ms. Rosapep was a Senior Associate at Abt Associates where she served as the senior administrator on Abt’s Institutional Review Board (IRB) and was a Research, Monitoring and Evaluation Lead on the USAID-funded Sustaining Health Outcomes through the Private Sector Plus (SHOPS Plus) and Strengthening Health Outcomes through the Private Sector (SHOPS) projects.

Outside of work, Ms. Rosapep serves in the Washington, D.C. chapter of Back on My Feet, a nonprofit organization that combats homelessness through the power of fitness, community support, and essential employment and housing resources.

Ms. Rosapep holds an MA in Social Service Administration from the University of Chicago and a BS in Foreign Service from Georgetown University.

The post Lauren Rosapep appeared first on Results for Development.

Dr. Chakraborty will oversee mixed health system program design and implementation at R4D — including the Frontier Health Markets Global Technical Assistance program — with the goal of optimizing public-private engagement within health systems to equitably deliver high-quality health care for all. She will collaborate closely with other R4D practice areas such as health financing and market shaping.

“I am thrilled to welcome Dr. Chakraborty to R4D,” said Tanya Jones, managing director at R4D. “Dr. Chakraborty’s extensive career as a global leader in mixed health systems will enable us to build on R4D’s deep engagement in this field. Throughout her career, Dr. Chakraborty has been a longtime champion of taking a systems approach and working with public and private sector actors to drive sustainable change and equitable health outcomes. I’m confident she will continue to push our thinking on how to improve mixed health systems around the world.”

Since it was founded in 2008, R4D has helped build the global evidence base on how to strengthen mixed health systems — beginning with an influential 2009 report, Public Stewardship of Private Providers in Mixed Health Systems, authored by Gina Lagomarsino, R4D’s president and CEO, and others. More recently, R4D implemented the Strengthening Mixed Health Systems project, which supported governments and private sector actors in India and Kenya to demonstrate and document practical and actionable processes for integrating quality private maternity care into government-stewarded health systems. Now, as the technical co-lead for the Frontier Health Markets Global Technical Assistance program — a 5-year USAID-funded initiative, valued at up to $135 million — R4D will build upon this past work to increase private sector engagement in countries where USAID currently supports family planning and other health activities to address key market challenges.

Dr. Chakraborty is a natural fit to lead this work. Throughout her career, she has focused on supporting low- and middle-income countries to diagnose and address gaps in access to quality health care with the objective of driving equitable health outcomes. She has championed a systems approach and working with public and private sector actors, working with a variety of organizations — from multilaterals to governments, to the private sector, and public-private partnerships. This has given her an expanded understanding of the perspectives of multiple stakeholders and how to bring them together to drive sustainable health systems to change.

“I am honored to join R4D to lead the mixed health systems practice,” said Dr. Chakraborty. “R4D has been a pioneer in shaping our understanding of mixed health systems, and we have learned a lot about how these systems work or do not work. It is now time to accelerate efforts to bring this evidence and knowledge to the forefront and support countries in building strong mixed health systems to achieve their health system goals. I believe R4D´s vision and mission are well suited to drive this change and I am excited to be part of this journey.”

Before R4D, Dr. Chakraborty spent 17 years with the World Bank, where she primarily worked on health sector projects in Europe and Central Asia, and the East Asia and Pacific Region. She spent seven years working with innovative pharmaceutical companies, including Merck KgAA/EMD Serono and Roche, in Germany and Switzerland, where she led topics such as global health, access strategies for low- and middle-income countries, and public-private partnerships. She designed major platforms such as Healthy Women, Healthy Economies, and Access Accelerated. Most recently she has been working in Geneva with the Global Fund and WHO.

Dr. Chakraborty holds a doctorate in health policy and management from Johns Hopkins University, a master’s degree in health planning and financing from the London School of Economics, and a bachelor’s degree in anthropology and economics from Mount Holyoke College. She is a native speaker of English and Bengali, and speaks German and basic French, and Turkish.

###

About Results for Development
Results for Development (R4D) is a leading non-profit global development partner. We collaborate with change agents — government officials, civil society leaders, and social innovators — supporting them as they navigate complex change processes to achieve large-scale, equitable outcomes in health, education, and nutrition. We work with country leaders to diagnose challenges, co-create, innovate and implement solutions built on evidence and diverse stakeholder input, and engage in learning to adapt, iterate and improve. We also strengthen global, regional and country ecosystems to support country leaders with expertise, evidence, and innovations. R4D helps country leaders solve their immediate challenges today, while also strengthening systems and institutions to address tomorrow’s challenges. And we share what we learn so others around the world can achieve results for development too. www.R4D.org

The post Dr. Sarbani Chakraborty joins R4D as new mixed health systems lead appeared first on Results for Development.

Dr. Chakraborty is a senior program director at Results for Development (R4D), where she oversees the mixed health systems (MHS) practice area. In this role, she manages partner and donor relationships, thought leadership, and program design and implementation for mixed health systems, including for the Frontier Health Markets Global Technical Assistance program, a 5-year USAID-funded initiative that aims to increase private sector engagement to improve voluntary family planning, maternal and child health, malaria and HIV/AIDS, for which R4D is the technical co-lead.

Throughout her career, Dr. Chakraborty has focused on helping low and middle-income countries diagnose and address gaps in access to quality health care with the objective of driving equitable health outcomes. She has, for many years, been a champion of taking a systems approach and working with public and private sector actors to drive sustainable change. She has worked with a variety of organizations involved in global health – multilateral (World Bank), governments, private sector, and public-private partnerships (Global Fund). This has given her an expanded understanding of the perspectives of multiple stakeholders and how to bring stakeholders together at the country and global levels to drive sustainable health systems change.

Prior to joining R4D, Dr. Chakraborty spent 17 years with the World Bank. At the Bank, she spent a few years working on education and the bulk of her time on World Bank health sector projects in Europe and Central Asia, and the East Asia and Pacific Region. She spent seven years working with innovative pharmaceutical companies (Merck KgAA/EMD Serono and Roche) in Germany and Switzerland where she led topics such as global health, access strategies for LMICs, and public-private partnerships. She designed major PPP platforms such as Healthy Women, Healthy Economies, and Access Accelerated. Most recently she has been working in Geneva with the Global Fund and WHO.

Dr. Chakraborty holds a PhD and master’s in public health in international health/health policy and management from the Johns Hopkins Bloomberg School of Public Health, an MSc in social policy/health planning and financing from the London School of Economics, and a BA in anthropology and economics from Mount Holyoke College. She is a native speaker of English, Bengali, and speaks German and basic French, and Turkish.

The post Sarbani Chakraborty appeared first on Results for Development.

Dr. Bossert’s innovative “decision space” approach to decentralization of health systems has appeared in many peer-reviewed journals, including Social Science and Medicine, Health Policy and Planning, WHO Bulletin, The Lancet and recently in an edited book on decentralization. Many other researchers are using his decision space approach. His pioneering work on sustainability of donor funded projects was published in Social Science and Medicine in 1990 and has influenced the field since. He also has directed a tool for WHO on strategic planning of human resources for health and other publications on the topic. He teaches courses, does research and evaluation, and provides technical assistance on health system reform, decentralization and human resources for Harvard, World Bank, USAID and other donors.

He is currently supporting the Harvard T. H. Chan School of Public Health participation in the Biden/Harris Partnership for Central America.

Dr. Bossert earned his AB from the School of Public and International Affairs (formerly Woodrow Wilson School) at Princeton University and MA and PhD in political science from the University of Wisconsin, Madison. He is fluent in Spanish and has a working knowledge of French.

The post Thomas J. Bossert appeared first on Results for Development.

Ms. O’Hanlon is assisting the World Bank Global Finance Facility as private sector advisor to integrate private sector themes in the Investment Case and incorporate strategies to involve the private sector in the Country Platform. She has helped multiple countries (Bangladesh, Central African Republic, Ethiopia, Ivory Coast, Myanmar, Niger, Nigeria) integrate private sector activities into GFF Investment Case, Country Platform and assisting Ivory Coast, Myanmar, and Niger implement private sector engagement projects.

She collaborated with the World Health Organization’s Health System’s Governance and Policy Department of Health Systems Governance and Financing to create awareness and build evidence on the importance of engaging the private health sector to achieve important health goals such as universal health coverage (UHC) and address COVID-19. She also developed policy briefs, guidance notes and instructional videos focused on private sector role to support low-and-middle-income countries (LMIC) health ministries tackle COVID-19 and roll out the COVID-19 vaccine.

Over the course of her career, Ms. O’Hanlon has led and participated in over 26 private sector assessments in Latin America and Caribbean, Africa, Central Asia, and South Asia. She co-developed a methodology to carry out private sector assessments and developed global knowledge and learning products such as Public-Private Dialogue Note and MM4H Executive Training Course. She also co-authored Managing Markets for Health.

In the last 18 years, she has worked with several African health ministries to conduct private health sector assessments, analyze key health markets for private sector opportunities, formulate private sector policies, and establish health PPP Units. She has also assisted several healthcare federations in Africa to become viable membership organizations and strengthen their technical capacity to represent the private sector voice in policy design and implementation.  She has trained health ministry officials from over 15 countries and development partner public health staff in the managing health markets approach.

Ms. O’Hanlon is a founding member of the World Health Organization’s Advisory Group on the Governance of the Private Sector for Universal Health Coverage.

Ms. O’Hanlon has an MPP from the John F. Kennedy School of Public Policy at Harvard University. A native English speaker, she is fluent in Spanish and conversant in French.

The post Barbara O’Hanlon appeared first on Results for Development.

At Results for Development (R4D), Dr. Bhanot is technical director for the Frontier Health Markets, Global Technical Assistance project where he is responsible for technical and thought leadership and strategic direction. He works closely with implementing partners, government counterparts, USAID mission staff and other stakeholders to improve health markets and promote public-private engagement for improved health outcomes.

In his career, Dr. Bhanot has served as project director, technical expert, and quality improvement specialist on several multimillion-dollar FP/RH, MNCH, HIV, TB and NCD interventions. He led development of market intelligence plans and facilitated communications between key suppliers, manufacturers, marketers, procurement agencies, and regulators to drive access to services and technologies while strengthening the capacity of facility and community providers in multiple states in India and countries in Asia and Africa.

In a prior role as deputy director for the Clinton Health Access Initiative, Dr. Bhanot facilitated introduction of new treatment devices and contraceptive technologies for cervical cancer and FP/RH interventions within state health programs in India. He also strengthened the supply chain to improve forecasting, quantification, procurement, distribution, and online information systems. As project director for health for the Palladium Group, he oversaw development and implementation of programs across Africa and Asia. He also worked with PSI on various health projects.

Dr. Bhanot holds an MBBS (bachelor of medicine and surgery) degree and an MD degree from leading medical institutes in India. He is a native speaker of English and speaks fluent Hindi.

The post Amit Bhanot appeared first on Results for Development.